Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 79

Results For "Import"

1887 News Found

Aurobindo to launch HIV triple combination product for children living with HIV in low and middle-income countries
News | August 17, 2023

Aurobindo to launch HIV triple combination product for children living with HIV in low and middle-income countries

Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon


Lupin Launches Tiotropium Dry Powder for Inhaler for COPD in US
News | August 17, 2023

Lupin Launches Tiotropium Dry Powder for Inhaler for COPD in US

Lupin actively contributes to alleviating the burden of COPD for patients across the nation


Cipla launches knowledge sharing platform ‘Ciplamed 2.0’
Digitisation | August 16, 2023

Cipla launches knowledge sharing platform ‘Ciplamed 2.0’

CiplaMed 2.0 leverages advanced analytics and automation


National Medical Library has a pivotal role to play in making medical education accessible to all via digital platform: Dr Pawar
Policy | August 14, 2023

National Medical Library has a pivotal role to play in making medical education accessible to all via digital platform: Dr Pawar

Continuous learning is not just an option but a responsibility that every healthcare professional must shoulder


India is set to become the global hub of medical technology and devices: Dr Mandaviya
News | August 11, 2023

India is set to become the global hub of medical technology and devices: Dr Mandaviya

The medical device sector is considered as one of the sunrise sectors in the country


Govt. passes National Dental Commission Bill, 2023
Policy | August 09, 2023

Govt. passes National Dental Commission Bill, 2023

The National Dental Commission Act 2023, will introduce a groundbreaking regulatory framework by establishing the National Dental Commission


Jemperli plus chemotherapy approved in the US as the first new frontline treatment option for dMMR/MSI-H primary advanced or recurrent endometrial cancer
Drug Approval | August 01, 2023

Jemperli plus chemotherapy approved in the US as the first new frontline treatment option for dMMR/MSI-H primary advanced or recurrent endometrial cancer

Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy


Mandaviya chairs 7th meeting of Central Institute Body of AIIMS and Chintan Shivir at NIHFW, Delhi
News | July 31, 2023

Mandaviya chairs 7th meeting of Central Institute Body of AIIMS and Chintan Shivir at NIHFW, Delhi

Chintan Shivir has provided a platform to hold discussions with higher officials and experts, which will help in evolving better practices of premier health institutions like AIIMS


AiMeD expresses dismay over FICCI’s ‘Un-Make in India’ drive
News | July 29, 2023

AiMeD expresses dismay over FICCI’s ‘Un-Make in India’ drive

Unfortunate to see PM’s ‘Make in India’ dream being bulldozed